One Park Avenue is a clinical research site located in New York, New York, United States 10016.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
One Park Avenue has participated in 1 clinical trials.
Therapeutic areas: HbA1c, Diabetes.
Sponsors: NYU Langone Health.
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
One Park Avenue has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
One Park Avenue has 1 clinical trials on record. Their work covers HbA1c, Diabetes.
One Park Avenue has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.